The use of erythropoiesis‐stimulating agents is safe and effective in the management of anaemia in myelofibrosis patients treated with ruxolitinib
暂无分享,去创建一个
M. Boccadoro | V. Martinelli | D. Cilloni | D. Ferrero | G. Palumbo | N. Pugliese | M. Cerrano | M. Marchetti | E. Elli | E. Crisà | E. Beggiato | Chiara Frairia | G. Lanzarone | M. Mezzabotta